Loading publications…
The last 5 uploaded publications
Risk of Venous Thromboembolism and Clinical Manifestations in Carriers of Antithrombin, Protein C, Protein S Deficiency, or Activated Protein C Resistance
Paolo Bucciarelli, Frits R. Rosendaal, Armando Tripodi, Pier Mannuccio Mannucci, Valerio De Stefano, Gualtiero Palareti, Guido Finazzi, F. Baudo, Roberto Quintavalla (1999). Risk of Venous Thromboembolism and Clinical Manifestations in Carriers of Antithrombin, Protein C, Protein S Deficiency, or Activated Protein C Resistance. Arteriosclerosis Thrombosis and Vascular Biology, 19(4), pp. 1026-1033, DOI: 10.1161/01.atv.19.4.1026.
Article126 days agoVenous Thrombosis Risk after Cast Immobilization of the Lower Extremity: Derivation and Validation of a Clinical Prediction Score, L-TRiP(cast), in Three Population-Based Case–Control Studies
Banne Nemeth, Raymond A. van Adrichem, Astrid van Hylckama Vlieg, Paolo Bucciarelli, Ida Martinelli, Trevor Baglin, Frits R. Rosendaal, Saskia le Cessie, Suzanne C. Cannegieter (2015). Venous Thrombosis Risk after Cast Immobilization of the Lower Extremity: Derivation and Validation of a Clinical Prediction Score, L-TRiP(cast), in Three Population-Based Case–Control Studies. PLoS Medicine, 12(11), pp. e1001899-e1001899, DOI: 10.1371/journal.pmed.1001899.
Article126 days agoPatients With Type 3 Severe von Willebrand Disease Are Not Protected Against Atherosclerosis
A. Šrámek, Paolo Bucciarelli, Augusto B. Federici, Pier Mannuccio Mannucci, Vincenzo De Rosa, Giancarlo Castaman, Massimo Morfini, Maria Gabriella Mazzucconi, Angiola Rocino, M. Schiavoni, F. A. Scaraggi, J.H.C. Reiber, Frits R. Rosendaal (2004). Patients With Type 3 Severe von Willebrand Disease Are Not Protected Against Atherosclerosis. Circulation, 109(6), pp. 740-744, DOI: 10.1161/01.cir.0000112567.53841.10.
Article126 days agoPredictors of von Willebrand disease diagnosis in individuals with borderline von Willebrand factor plasma levels
Paolo Bucciarelli, Simona Maria Siboni, Francesca Stufano, Eugenia Biguzzi, Maria Teresa Canciani, Luciano Baronciani, M Pagliari, Silvia La Marca, Charles A. Mistretta, Frits R. Rosendaal, Flora Peyvandi (2014). Predictors of von Willebrand disease diagnosis in individuals with borderline von Willebrand factor plasma levels. Journal of Thrombosis and Haemostasis, 13(2), pp. 228-236, DOI: 10.1111/jth.12799.
Article126 days agoTargeted sequencing to identify novel genetic risk factors for deep vein thrombosis: a study of 734 genes
Hugoline G. de Haan, Astrid van Hylckama Vlieg, Luca A. Lotta, Marcin M. Gorski, Paolo Bucciarelli, Ida Martinelli, Trevor Baglin, Flora Peyvandi, Frits R. Rosendaal, Philippe Amouyel, M. de Andrade, Saonli Basu, Claudine Berr, J.A. Brody, Daniel I. Chasman, Jean‐François Dartigues, Aaron R. Folsom, Marine Germain, John A. Heit, Jeanine Houwing-Duitermaat, Christopher Kabrhel, Peter Kraft, Grégoire Le Gal, Sara Lindstrӧm, Ramin Monajemi, Pierre‐Emmanuel Morange, B.M. Psaty, Pieter H. Reitsma, Paul M. Ridker, L.M. Rose, Noémie Saut, P. Eline Slagboom, David M. Smadja, Nicholas L. Smith, P. Suchon, W.H. Wilson Tang, Kent D. Taylor, David‐Alexandre Trégouët, Christophe Tzourio, Marieke C. Visser, Lu‐Chen Weng, K.L. Wiggins (2018). Targeted sequencing to identify novel genetic risk factors for deep vein thrombosis: a study of 734 genes. Journal of Thrombosis and Haemostasis, 16(12), pp. 2432-2441, DOI: 10.1111/jth.14279.
Article126 days ago